Given the neuroprotective effects of both GLP-1 and estradiol, it would also be interesting to know how such agents might reduce neurodegeneration, especially in menopausal women
DOI: 10.3389/fimmu.2024.1385006 [Google Scholar] Dees C, Chakraborty D, Distler JHW
Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH Abstract: Emerging as a major global health concern, metabolic dysfunction-associated steatohepatitis (MASH) is closely linked to obesity, type 2 diabetes, and other metabolic disorders
Receptor-focused refinment maps for conformer 1 (i) and conformer 2 (n)
With a combination of fenfluramine or dexfenfluramine (appetite suppressants) and phentermine (an amphetamine), demand for the drug soared and many doctors doled out prescriptions
They are early adopters, trend seekers, and status-driven consumers who are simultaneously health-conscious and self-described as impulsive